EditorialThe Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?Dragovic, Aleksandar F. MD Author Information From the Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI. The author has disclosed that he has no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Reprints: Aleksandar F. Dragovic, MD, Department of Radiation Oncology, University of Michigan, UH B2C490, 1500 E. Medical Center Dr SPC 5948, Ann Arbor, MI 48109-5948. E-mail: [email protected]. The Cancer Journal: 3/4 2022 - Volume 28 - Issue 2 - p 93-95 doi: 10.1097/PPO.0000000000000582 Buy Metrics Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.